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Abstract Chlamydia trachomatis may infect the placenta
and subsequently lead to preterm delivery. Our aim was to
evaluate the relationship between the presence of Chla-
mydia trachomatis and signs of placental inﬂammation in
women who delivered at 32 weeks gestation or less. Set-
ting: placental histology and clinical data were prospec-
tively obtained from 304 women and newborns at the
Erasmus MC-Sophia, Rotterdam, the Netherlands. C. tra-
chomatis testing of placentas was done retrospectively
using PCR. C. trachomatis was detected in 76 (25%)
placentas. Histological evidence of placental inﬂammation
was present in 123 (40%) placentas: in 41/76 (54%) pla-
centas with C. trachomatis versus 82/228 (36%) placentas
without C. trachomatis infection (OR 2.1, 95% CI 1.2–3.5).
C. trachomatis infection correlated with the progression
(P = 0.009) and intensity (P = 0.007) of materno-fetal
placental inﬂammation. C. trachomatis DNA was fre-
quently detected in the placenta of women with early
preterm delivery, and was associated with histopatholo-
gical signs of placental inﬂammation.
Keywords Chlamydia trachomatis   Placental
inﬂammation   Pregnancy   Prematurity
Introduction
Preterm birth is the main cause of perinatal morbidity and
mortality worldwide accounting for 60–80% of deaths of
infants born without congenital abnormalities [1]. Preterm
labor is associated with placental inﬂammation, especially
with acute chorioamnionitis [2, 3]. Many studies associated
clinical and histological chorioamnionitis with acute neo-
natal morbidity and mortality and, at least to some degree,
also with neurological impairments and chronic lung dis-
ease [4–8].
Chlamydia trachomatis is the most common bacterial
sexually transmitted infection worldwide, including in the
Netherlands [9]. Starting as cervicitis, chlamydial infection
may ascend and infect the placenta or amniotic ﬂuid, which
may subsequently lead to preterm delivery. The literature
regarding the association of maternal C. trachomatis
infection with preterm delivery, however, is conﬂicting due
to differences in study design, population and microbio-
logical test methods [10–24].
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DOI 10.1007/s10654-011-9569-2The aims of this study were to detect C. trachomatis
infection in placentas of women with early preterm deliv-
ery and to associate C. trachomatis infection with histo-
logical signs of placental inﬂammation. The literature is
very limited regarding this association, but may be relevant
to explain a component causal effect of C. trachomatis
infection on preterm delivery. In addition, we studied the
association of C. trachomatis infection with delivery
characteristics and neonatal outcome in this selected cohort
of women.
Methods
Patients and design
The chorioamnionitis study, during which the placentas
were collected that we used in the current Chlamydia tra-
chomatis study, was prospective, observational, and non-
interventional. Pregnant women, who delivered live new-
borns between May 2001 and February 2003 at the Erasmus
MC-Sophia,Rotterdam,theNetherlands,atagestationalage
of 32 weeks or less, were eligible for the study. Regular
health care workers (residents, research-nursing staff, neo-
natologists)informedthewomenaboutthestudy.Enrolment
took place immediately after delivery when the newborns
were admitted to the neonatal intensive care unit. Women
were excluded from the study if the placenta was not
available for histological examination and, at a later stage, if
no more placental tissue was available to test for C. tra-
chomatis. Antenatal, perinatal and neonatal data were
obtained from maternal and neonatal medical records and
prospectively stored in a database. Follow up of neonates
was until a postnatal age of 28 days or postmenstrual age of
36 weeks. Neonates, who were transferred to another hos-
pital, were followed in order to complete the data. Placentas
were examined for evidence of infection or other pathology.
Retrospectively, the placentas were examined for the pres-
ence of C. trachomatis.
Maternal ethnicity was self-classiﬁed in this study. In
total 32 different nationalities were registered. Most women
were Dutch (70%), Turkish (7%), Surinamese (4%) or
Moroccan (3%). Nationalities were clustered in six ethnic
groups: Central European, Eastern European, Mediterra-
nean, Caribbean/South-American, Azian and African. We
used the following deﬁnitions. Clinical signs of chorioam-
nionitis were recorded and deﬁned by the presence of two or
more of the following signs: abdominal pain, cervical dis-
charge, leucocytosis (white blood cell count C15 9 10
9/l),
fever (maternal temperature [38C), and raised CRP
(C-reactive protein C15 l/L). Pre-eclampsia was deﬁned as
new-onset hypertension (blood pressure [140/90 mmHg)
with proteinuria [25]. Fetal distress was considered present
when indicated by the obstetrician based on cardiotoco-
graphic criteria. Gestational age was estimated by ultraso-
nography or by using the last menstrual period when
reliable. Small for gestational age (SGA): birth weight less
thantwostandarddeviationsofthemeanforgestationalage.
Respiratory distress syndrome (RDS)was deﬁned according
to Giedeon [26]. Broncho-pulmonary dysplasia (BPD):
dependency on oxygen supplementation at a postmenstrual
age of 36 weeks. Intraventricular haemorrhage (IVH) and
periventricular leucomalacia (PVL) were deﬁned according
to Volpe [27]. Necrotising enterocolitis (NEC) was deﬁned
as stage two or higher according to Bell [28].
Histopathology
Immediately after delivery placentas and membranes were
ﬁxed in formalin for at least 16 h. Sampling was performed
according to a standard protocol with two membrane rolls,
two cross sections of the cord and three representative
blocks of the placental disk as a minimum. The tissues
were thereafter, according to routine standard methodology
for pathological specimens, embedded in parafﬁn until
histopathological examination. To prevent inter-examiner
variation, the same pathologist who was specialized in
perinatal pathology examined all placentas for histological
evidence of inﬂammation. The pathologist was blinded to
clinical information. Placental inﬂammation was catego-
rized according to a maternal inﬂammatory response (MIR)
and fetal inﬂammatory response (FIR) as suggested by the
Amniotic Fluid Infection Nosology Committee [29], and
was considered positive if there was any evidence of a MIR
and/or FIR. The MIR was divided into three stages (acute
subchorionitis or chorionitis, acute chorioamnionitis, nec-
rotizing chorioamnionitis) representing progression of
disease, and two grades representing intensity of disease;
the FIR was similarly divided into three stages (chorionic
vasculitis or umbilical phlebitis, umbilical vasculitis or
umbilical panvasculitis, (subacute) necrotizing funisitis or
concentric umbilical perivasculitis) and two grades [29].
After histopathological examination, the placentas were
stored in parafﬁn blocks at room temperature. Before
testing for C. trachomatis, the parafﬁn blocks were cut on
different days using the same microtome with single use
disposable blades. Care was taken to clean materials
between cases to avoid contamination. The parafﬁn blocks
were cut until the surface was straight after which ﬁve
samples per parafﬁn block each of 10 lm thickness were
cut for further microbiological analysis.
Microbiology
For DNA Isolation, tissue samples were deparafﬁnized
with xylene at room temperature and washed in ethanol.
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123Bacterial DNA was isolated using the QIA Amp Tissue Kit
(QIAgen, Hilden, Germany). After a ﬁrst lysis with pro-
teinase K, DNA was bound to a QIAamp spin column, the
column washed twice, the puriﬁed DNA eluded from the
column in an elution buffer AE, and preheated at 70C.
For DNA ampliﬁcation and detection, a Real-time PCR
was carried out using the Lightcycler 2.0 system and
FastStart DNA Master SYBR Green I kit (Roche Diag-
nostics, Almere, The Netherlands). Each PCR reaction
contained 3 mM MgCl2 and 0.5 lM of each of the two
primers NLO 50-ATGAAAAAACTCTIGAAATCG-30
(position 1–21) and NRO 50-CTAACTGTAACTGCGT-
ATTT-30 (position 1128–1108) to amplify C. trachomatis
plasmid DNA [30], was denatured for 10 min at 95C,
subjected to 40 cycles of 15 s at 95C, 10 s at 60C and
20 s at 72C. To check the speciﬁcity of ampliﬁcation
products, a melting curve analysis was performed consist-
ing of heating from 65 to 95C at a rate of 0.1 s per step
and holding for 20 s at each step for data acquisition. The
melting temperature for the speciﬁc amplicons was 82C.
For each sample, the PCR was done using a separate
internal validation (b-globine PCR). For each run a nega-
tive control (water) and three positive controls (dilutions of
puriﬁed C. trachomatis) were included.
Ethical aspects
The study was approved by the Medical Ethics Committee
for Research on Human Subjects of the Erasmus MC,
Rotterdam, the Netherlands.
Statistical analysis
Statistical analysis was performed using the Statistical
Package of Social Sciences version 11.0 for Windows
(SPSS Inc. Chicago, Illinois, USA). Since pre-eclampsia
and chorioamnionitis are two distinct potential pathways to
preterm delivery, stratiﬁed analysis was done regarding the
differences in maternal morbidity. For comparison of cat-
egorical variables between groups the Pearson’s Chi-square
test or Fisher’s Exact test was used. For comparison of
continuous variables the two-tailed Student’s T-test was
used. The Mantel–Haenszel test was used to asses trends.
Statistical signiﬁcance was considered P\0.05.
Results
Three hundred and twenty-three pregnant women were
eligible for the study. Placental tissue and clinical data
were available for 304 (94%) women and their newborns.
C. trachomatis in relation to clinical characteristics
C. trachomatis was detected by PCR in placental tissue of
76/304 (25%) women. One woman had a record of
C. trachomatis infection prior to the current pregnancy.
Three women were tested and found to be positive during
the current pregnancy. None of these women had C. tra-
chomatis detected in their placenta. Eighty-four women
received antibiotics for PPROM or signs of infection.
Chlamydia-positive women received more often antibiotics
than chlamydia-negative women: 32/76 (42%) versus
52/228 (23%); (OR 2.5, 95% CI 1.4–4.4), and received
more often erythromycin: 14 (18%) versus 20 (9%); (OR
2.4, 95% CI 1.1–5.2). Amoxicillin-clavulanic acid and
amoxicillin were prescribed more often to chlamydia-
positive women, but did not differ signiﬁcantly between the
two groups: 19 (25%) versus 36 (16%); (OR 1.8; 95% CI
0.9–3.3).
Antenatal, clinical and delivery characteristics of
women with and without C. trachomatis infection are
compared in Table 1. Maternal age, parity, and gravidity
were similar for women in both groups and the distribution
of chlamydial detection was homogenous among ethnic
groups (P = 0.8). Presence of two or more clinical signs of
chorioamnionitis was not signiﬁcantly more often observed
among chlamydia-positive women than among chlamydia-
negative women. PROM did not differ between the two
groups. Chlamydia-positive women had signiﬁcantly less
often pre-eclampsia (P = 0.002) and delivered signiﬁ-
cantly less often after fetal distress (P = 0.03) and by
caesarean section (P = 0.002) than chlamydia-negative
women, and their newborns were signiﬁcantly less often
small for their gestational age (P = 0.02). Neonatal out-
comes such as RDS, BPD, IVH, PVL, and neonatal mor-
tality rate were not signiﬁcantly different between neonates
born to chlamydia-positive and chlamydia-negative women
(data not shown).
Since the above-mentioned differences could be due to
the differences in maternal morbidity (women without and
with pre-eclampsia), a stratiﬁed analysis was performed as
shown in Table 2. After stratiﬁcation, the differences
between chlamydia-positive and chlamydia-negative
women became non-signiﬁcant. Among the women with
pre-eclampsia, neonates born to chlamydia-positive women
were less often small for gestational age than those born to
chlamydia-negative women (P = 0.02). Neonatal out-
comes as BPD, IVH, PVL and neonatal mortality rate were
not signiﬁcantly different between strata (data not shown),
but RDS grade I–II was observed more often in neonates
born to 9/17 (53%) chlamydia-positive women with pre-
eclampsia than in 25/96 (26%) chlamydia-negative women
with pre-eclampsia (OR 3.2; 95% CI 1.1–9.2; P = 0.03).
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123Table 1 Clinical characteristics
of pregnancies according to
Chlamydia trachomatis status
Numbers are mean ± SD or
number (%), n number, OR odds
ratio, CI conﬁdence interval, NA
not applicable, CA
chorioamnionitis, PROM
premature rupture of
membranes
C. trachomatis negative
(n = 228)
C. trachomatis positive
(n = 76)
OR (95% CI)
Antenatal characteristics
Maternal age 30.9 ± 5.3 30.1 ± 5.0 NA
Para 1.8 ± 1.3 1.9 ± 1.1 NA
Gravida 2.2 ± 1.7 2.0 ± 1.2 NA
Clinical characteristics
C2 clinical signs CA 48 (21) 24 (32) 1.7 (0.97–3.1)
Fetal distress 114 (50) 27 (36) 0.6 (0.3–1.0)
PROM 63 (28) 24 (32) 1.3 (0.7–2.2)
Pre-eclampsia 96 (42) 17 (22) 0.4 (0.2–0.7)
Delivery characteristics
Caesarean section 146 (64) 33 (43) 0.4 (0.3–0.8)
Gestational age 29.1 ± 1.9 29.1 ± 1.9 NA
Birth weight (gram) 1,124 ± 347 1,207 ± 350 NA
Small for gestational age 67 (29) 12 (16) 0.5 (0.2–0.9)
Table 2 Clinical characteristics
according to Chlamydia
trachomatis status by strata of
pre-eclampsia
Numbers are mean ± SD or
number (%), n number, OR odds
ratio, CI conﬁdence interval, NA
not applicable, CA
chorioamnionitis, PROM
premature rupture of
membranes, SGA small for
gestational age. Analysis with
Pearson’s Chi-square test or
Fisher’s Exact test; * P = 0.02
C. trachomatis negative C. trachomatis positive OR (95% CI)
No pre-eclampsia n = 132 (69) n = 59 (31)
Antenatal characteristics
Maternal age 30.8 ± 5.1 30.1 ± 4.8 NA
Para 1.9 ± 1.3 1.9 ± 1.1 NA
Gravida 2.3 ± 1.7 2.0 ± 1.2 NA
Clinical characteristics
C2 clinical signs CA 47 (36) 24 (41) 1.2 (0.7–2.3)
Fetal distress 41 (31) 16 (27) 0.8 (0.4–1.6)
PROM 60 (45) 24 (41) 0.8 (0.4–1.5)
Delivery characteristics
Caesarean section 59 (45) 20 (34) 0.6 (0.3–1.2)
Gestational age 28.8 ± 2.0 29.1 ± 2.0 NA
Birth weight (gram) 1,194 ± 354 1,223 ± 359 NA
SGA 18 (14) 9 (15) 1.1 (0.5–2.7)
Pre-eclampsia n = 96 (85) n = 17 (15)
Antenatal characteristics
Maternal age 31.1 ± 5.6 30.0 ± 5.7 NA
Para 1.7 ± 1.2 1.8 ± 1.1 NA
Gravida 2.0 ± 1.7 1.9 ± 1.2 NA
Clinical characteristics
C2 clinical signs CA 1 (1) 0 (0) NA
Fetal distress 73 (76) 11 (65) 0.6 (0.2–1.7)
PROM 3 (3) 1 (6) 1.9 (0.2–19.8)
Delivery characteristics
Caesarean section 87 (91) 13 (77) 0.3 (0.1–1.3)
Gestational age 29.5 ± 1.7 29.1 ± 1.8
Birth weight (gram) 1,027 ± 314 1,151 ± 321
SGA* 49 (51) 3 (18) 0.2 (0.06–0.7)
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123C. trachomatis in relation to histological signs
of placental inﬂammation
Histologicalevidenceofplacentalinﬂammationwaspresent
in 123/304 (40%) women of whom 64 (52%) had inﬂam-
mationdiagnosedinbothmaternalandfetaltissue,50(41%)
in maternal tissue only, and four (3%) in fetal tissue only.
Five (4%) placentas showed other speciﬁc features includ-
ing peripheral funisitis, acute villitis, acute intervillositis
with intervillous abscesses, or the presence of decidual
plasma cells, but had no signs of a maternal or fetal
inﬂammatory response. Chlamydia-positive women had
signiﬁcantly more often histopathological signs of placental
inﬂammation than chlamydia-negative women: 41/76
(54%) versus 82/228 (36%); (OR 2.1, 95% CI 1.2–3.5).
The progression and intensity of inﬂammation of
maternal tissue only and the combination of maternal and
fetal tissues were assessed in relation to C. trachomatis
infection (Table 3). For the latter combination, the highest
stage or grade of inﬂammation in either maternal or neo-
natal tissue was assessed in trend analysis. Chlamydia-
positive women had signiﬁcantly more often signs of
inﬂammation in both maternal and fetal tissue for pro-
gression stage 3 and intensity grade 2 in their placentas
than chlamydia-negative women. In addition, a signiﬁ-
cantly increasing trend towards more frequent detection of
C. trachomatis was observed with increasingly higher
scores for intensity (P = 0.04) involving maternal inﬂam-
mation only, and for progression (P = 0.009) and intensity
(P = 0.007) of inﬂammation involving both maternal and
fetal tissues.
Discussion
Chlamydia trachomatis DNA was detected in a high pro-
portion (25%) of placentas from women who had early
preterm delivery (B32 weeks) and was associated with
histopathological signs of placental inﬂammation.
The strength of this study is the prospective, observa-
tional design during which the placentas and clinical data
were obtained, the large number of well-described partic-
ipants, a high follow-up rate, and the use of nucleic acid
ampliﬁcation technique for the detection of C. trachomatis.
In order to prevent contamination of samples during the
process of cutting, during DNA isolation or during the PCR
test itself, precautions were taken. Parafﬁn blocks were cut
in badges on different days by two different people using a
similar microtome with single-use disposable blades, and
care was taken to clean materials between cases. In addi-
tion, the order of cutting was recorded and no clustering
was observed in the detection of C. trachomatis in the cuts.
Table 3 Risk of Chlamydia
trachomatis infection according
to progression and intensity of
placental tissue inﬂammation
# OR compared to placenta with
no inﬂammation,
## P = 0.01
Mantel–Haenszel trend
analysis: * P = 0.09,
** P = 0.04, *** P = 0.01
Placenta tissue Total, n C. trachomatis
positive, n (%)
OR (95% CI)
#
No placenta inﬂammation 181 35 (19) 1.0 (reference)
Any placenta inﬂammation
## 123 41 (33) 2.1 (1.2–3.5)
Maternal inﬂammation only 50 16 (32) 2.0 (0.98–4.0)
Progression*
Stage 1 24 8 (33) 2.1 (0.8–5.3)
Stage 2 20 6 (30) 1.8 (0.6–5.0)
Stage 3 6 2 (33) 2.1 (0.4–11.8)
Intensity**
Grade 1 43 13 (30) 1.8 (0.9–3.8)
Grade 2 7 3 (43) 3.1 (0.7–14.6)
Maternal and fetal inﬂammation 64 22 (34) 2.2 (1.2–4.1)
Progression***
Stage 1 4 1 (25) 1.4 (0.1–13.7)
Stage 2 20 6 (30) 1.8 (0.6–5.0)
Stage 3 40 15 (38) 2.5 (1.2–5.2)
Intensity***
Grade 1 25 7 (28) 1.6 (0.6–4.1)
Grade 2 39 15 (38) 2.6 (1.2–5.5)
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123In addition, DNA isolation was done on different days by
different laboratory technicians in different locations, and
pipetting was performed using aerosol-resistant tips. Fur-
thermore, the PCR was done using an internal validation (b-
globine PCR) for each sample separately, and for each run
using a negative control (water) and three positive controls
(dilutions of puriﬁed Chlamydia). None of the negative
controls became positive. Therefore, contamination seems
unlikely to have inﬂuenced the results of the study.
A limitation of the study is that we did not examine pla-
centas from full term pregnancies. Inclusion of term speci-
mens would have enabled additional assessment of the
contribution of C. trachomatis infection to placental
inﬂammation and its relation to prematurity. Unfortunately,
thechorioamnionitisstudywasinitiallynotdesignedassuch
andretrospectivelywewerenotabletotracetermspecimens
from women in the same region and time period for addi-
tional comparisons. Another limitation is that although a
large number of women participated in this study, the
numbers in each category after stratiﬁcation are small.
Furthermore, residual confounding as a result of co-infec-
tion by other pathogens was not tested as part of the study.
Indeed, the ﬁnding of many cases of placental inﬂammation
in the absence of C. trachomatis infection would support the
presence of other inﬂammation-inducing pathogens in this
cohort of women. Another limitation was that C. tracho-
matis testing was done retrospectively and that prospec-
tively no specimens were collected from infants, which
made it impossible to study vertical transmission.
The PCR technique has been used previously to detect
C. trachomatis in placentas [31–33], but reports focusing
on the use of PCR to detect Chlamydia in placentas of early
preterm deliveries are very limited and from much smaller
cohorts. One case report described a stillborn at 36 weeks
of gestation in whose placenta C. trachomatis was identi-
ﬁed [31]. In a Chinese study 59 specimens of chorionic villi
were examined that had been collected from women
attending an antenatal clinic for artiﬁcial abortion within
the ﬁrst trimester of pregnancy, of which three cases (5%)
were found to be C. trachomatis positive [32]. In a Cro-
atian study of women with a miscarriage between four and
19 weeks gestation, C. trachomatis was detected in only
one of 108 placental tissues examined [33].
A 25% prevalence of C. trachomatis in pregnant women
is high. It is much higher than the C. trachomatis preva-
lence (4%) found in one of our previous population-based
studies among 4,055 pregnant women in the same region
and time period, using the same test method on urines
instead of placentas, and for whom the referal centre is the
hospital in which women and neonates were enrolled for
the present study. However, our ﬁnding is similar to the
prevalence (18%) found in the women of the latter study
who delivered at 32 weeks gestation or less [34]. The
difference between these studies may be due to the fact that
the current study is hospital based instead of population
based, and because not all women who delivered prema-
turely participated in the other study. Although we were
not able to directly assess an association between C. tra-
chomatis infection and preterm delivery from the current
study, our ﬁndings support those found in the previous
study.
We found no signiﬁcant association of C. trachomatis
infection with clinical signs in women, neither in the total
group nor after stratiﬁcation. This is not surprising since up
to 80% of chlamydial infections in women are known to be
asymptomatic. In addition, urogenital symptoms are often
non-speciﬁc and likely to be regarded as part of the preg-
nancyinsteadofdiseaseandnottobereported.However,we
didﬁndanassociationbetweenC.trachomatisinfection and
histopathological signs of placental inﬂammation. Histo-
logically proven chorioamnionitis is considered the gold
standard against which other clinical predictors of inﬂam-
mation should be measured [2, 35, 36]. Histological evi-
dence of placental inﬂammation was present in 40% of the
women and signiﬁcantly more in chlamydia-positive
women than in chlamydia-negative women: 54 versus 36%.
Virtually all placentas had signs of maternal inﬂammation
whereas only half the time fetal inﬂammation was present.
Only maternal inﬂammation would be concordant with
infection originating from the maternal side. Our ﬁndings,
therefore, suggest that ascending C. trachomatis infection
during pregnancy may extend into the placental tissues.
Such invasion of placental tissue is likely to produce an
inﬂammatory response that may trigger preterm labor and
delivery [37]. Hence, in case of unexplained preterm
delivery additional information can be obtained from his-
topathological examination of placental tissue and from
testingforC.trachomatisusinghighlysensitivenucleicacid
ampliﬁcation techniques.
C. trachomatis is transmitted from mother to newborn
during passage through an infected birth canal. However,
there are several, mostly anecdotal, reports of newborns
delivered by caesarean section that were infected with C.
trachomatis [38–41]. Ascending chlamydial infection in
women undergoingcaesarean section may be due to PROM,
but the possibility of a transmembrane or transplacental
routehasalsobeensuggestedinthepathogenesisofneonatal
chlamydial infection [38, 40]. In our study 43% of chla-
mydia-positive women gave birth by caesarean section of
whom 27% had PROM. Since collection and testing of
specimensfromthenewbornswasnotincludedinthedesing
of the study, we are unable to conﬁrm the latter hypothesis.
Likewise, we cannot ascribe any neonatal respiratory dis-
ease, RDS stage I–II, to C. trachomatis infection.
The data presented are highly suggestive of C. tracho-
matis being a component cause of preterm delivery through
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123a pathway that involves a transmembrane or transplacental
route of transmission for chlamydial infection leading to
chorioamnionitis. Further studies regarding the role of
C.trachomatisineitherpathwayleadingtopretermdelivery
are needed.
Conclusion
C. trachomatis DNA was frequently detected in the pla-
centa of women with early preterm delivery and was
associated with signs of inﬂammation in the placenta.
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